Showing results (1-10 of 87) with videos related to
Sort By:
Pageof 9
European Journal of Pharmacology|September 16, 1983
Ascorbate-induced lipid peroxidation and the binding of [3H]dihydroalprenololR E HeikkilaEuropean Journal of Pharmacology|October 29, 1985
Differential neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in Swiss-Webster mice from different sourcesR E HeikkilaEuropean Journal of Pharmacology|July 15, 1977
The prevention of alloxan-induced diabetes in mice by dimethyl sulfoxideR E HeikkilaScience (New York, N.Y.)|August 3, 1973
6-Hydroxydopamine: evidence for superoxide radical as an oxidative intermediateR E Heikkila, G CohenEuropean Journal of Pharmacology|August 17, 1984
Behavioral properties of GBR 12909, GBR 13069 and GBR 13098: specific inhibitors of dopamine uptakeR E Heikkila, L ManzinoResearch Communications in Chemical Pathology and Pharmacology|January 1, 1981
The prevention of alloxan-induced diabetes by the immunosuppressive agent azathioprineR E Heikkila, F S CabbatJournal of Neurochemistry|November 1, 1983
Ascorbate-induced lipid peroxidation and inhibition of [3H]spiroperidol binding in neostriatal membrane preparationsR E Heikkila, F S CabbatLife Sciences|April 21, 1986
Prevention of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic toxicity in mice by MDL 72145, a selective inhibitor of MAO-BM V Kindt, R E HeikkilaEuropean Journal of Pharmacology|October 7, 1986
The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in miceP K Sonsalla, R E HeikkilaThe Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 1, 1987
The use of the MPTP-treated mouse as an animal model of parkinsonismR E Heikkila, P K SonsallaPageof 9